안중배 / AHN, Joong-Bae
부교수

Department / Institute / Center :
Internal Medicine
Yonsei Cancer Center

Contact Information

Phone +82-2-2228-8134 Email vvswm513@yuhs.ac Website

Educational Background

Undergraduate Education M.D. Yonsei University, College of Medicine 1990
Final Degree (University, Major) Ph.D. Yonsei University, Internal Medicine 2003
Overseas Training (Institute, Supervisor) M.D. Anderson Cancer Center, Jeon-Pierre Issa

Professional Societies and current positions

Korea Association of Internal Medicine
Korea Cancer Association
American Society of Clinical Oncology(ASCO)
American Association of Cancer Research(AACR)

Research Area(s)

Translational research, Clinical research, Drug trial
Research Field Role of DNA methylation In colon cancer.
Identification of new prediction, prognostic gastric in colon cancer.
Diseases Colorectal Cancer, Geniturinary Cancer.
Possible Collaboration DNA methylation.
대장암 치료 예측을 위한 표지마커 연구

Research Methods

Pyrosequencing.

Lab.

연구실사이트 바로가기
Location of Office 암센터 2층
Location of Lab. 암센터 4층
Contact person Name: / Tel: / E-mail:

Major Published Articles and Books

1. Ahn JB, Chung WB, Maeda O, Shin SJ, Kim HS, Chung HC, Kim NK, Issa JP. DNA methylation predicts recurrence from resected stage III proximal colon cancer. Cancer. 2010 Nov 18. [Epub ahead of print]. (First Author)

2. Shin SJ, Jeong JH, Park YS, Lee KH, Shim BY, Kim TW, Oh DY, Lee MA, Kim YT, Kim YH, Zang DY, Roh JK, Ahn JB. Phase II trial of S-1 monotherapy in elderly or frail patients with metastatic colorectal cancer. Invest New Drugs. 2010 Mar 21. [Epub ahead of print] (Corresopnding Author)

3. Shin SJ, Kim NK, Keum KC, Kim HG, Im JS, Choi HJ, Baik SH, Choen JH, Jeung HC, Rha SY, Roh JK, Chung HC, Ahn JB. Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancer. Radiother Oncol. 2010 Jun;95(3):303-7 (Corresopnding Author)

4. Ahn JB, Rha SY, Shin SJ, Jeung HC, Kim TS, Zhang X, Park KH, Noh SH, Roh jk, Chung HC. Circulating endothelial progenitor cells (EPC) for tumor vasculogenesis in gastric cancer patients. Cancer Lett. 2010 Feb 1;288(1):124-32. (First Author)